ECM
TSVT

Engine Capital Management’s 2seventy bio TSVT Stock Holding History

Engine Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-703,972
Closed -$3.48M – 35
2025
Q1 		$3.48M Hold
703,972
– – 0.66% 24
2024
Q4 		$2.07M Sell
703,972
-585,977
-45% -$2.4M 0.38% 26
2024
Q3 		$6.09M Sell
1,289,949
-204,355
-14% -$922K 1.06% 25
2024
Q2 		$5.75M Hold
1,494,304
– – 1.08% 22
2024
Q1 		$7.99M Hold
1,494,304
– – 1.61% 16
2023
Q4 		$6.38M Buy
1,494,304
+1,152,434
+337% +$3.54M 1.05% 19
2023
Q3 		$1.34M Buy
+341,870
New +$2.24M 0.3% 25

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engine Capital Management's TSVT Position: Q2 2025 in Review

Engine Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 703,972 shares — an estimated $3.48M sold.

Engine Capital Management first reported a position in TSVT in Q3 2023 and held it in 7 quarters. The position peaked at $7.99M in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Engine Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Engine Capital Management sold 703,972 2seventy bio shares in Q2 2025, an estimated $3.48M.
  • Engine Capital Management first reported a position in 2seventy bio in Q3 2023 and held it in 7 quarters.
  • Engine Capital Management's 2seventy bio position peaked at $7.99M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Engine Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.